HAVCR2 and acute myeloid leukemia: Taken together, our findings provide promising evidence on the generation of functional CAR-TIM3 NK-like cells for targeting primitive AML cells from a single-cell clonal master NK/iPSCs under serum-free and xeno-free conditions, which could be further developed into the Good Manufacturing Practice (GMP)-compliant protocols.